A Highly Protective Live-Attenuated Vaccine Generated by Targeted Deletion of the Mycobacterium bovis Virulence Factor VapC40
International Journal of Molecular Sciences · 01.05.2026 · 27 (9) · 4067
DOI: 10.3390/ijms27094067 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.05.2026. Verfasst von Xin Ge und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Mycobacterium bovis, Vaccines, Attenuated, Virulence Factors, Bacterial Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Type II toxin–antitoxin (TA) systems are significantly expanded in the Mycobacterium tuberculosis complex; however, the functional role of the VapBC40 system in Mycobacterium bovis (M. bovis) pathogenesis remains poorly characterized. This study aimed to investigate the role of VapBC40 in mycobacterial virulence and evaluate its potential as a target for rational vaccine attenuation. We performed evolutionary analysis and yeast two-hybrid assays to characterize VapBC40 system specificity, conducted in vitro macrophage infection models and in vivo murine studies to assess virulence contribution, and evaluated the immunoprotective efficacy of a VapC40 knockout strain. Evolutionary analysis revealed progressive sequence conservation and stringent homologous pairing specificity within the VapBC40 system. The VapC40 toxin correlates with enhanced intracellular bacterial survival, increased host cell death, and more severe pulmonary pathology with systemic dissemination. Based on these findings, we evaluated the vaccine potential of a vapC40 knockout strain. Immunization with this attenuated strain elicited a Th1 cellular immune response, characterized by enhanced IFN-γ production and increased frequency of CD4+IFN-γ+ T cells. Upon challenge with virulent M. bovis, the knockout strain conferred superior protection compared to the conventional BCG vaccine, significantly reducing lung pathology and restricting extrapulmonary bacterial dissemination. Although the molecular mechanisms underlying VapC40-mediated effects remain to be fully elucidated, our findings suggest an important role of the VapBC40 system in mycobacterial-host interactions and support its potential as a target for next-generation tuberculosis vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
ORCID-Profile: Yuhui Dong, Xiangmei Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ge, X., Wang, H., Liu, D., Dong, Y., Li, L., Shen, P., Li, Y., Zhang, J., Zhou, X., & Yue, R. (2026). A Highly Protective Live-Attenuated Vaccine Generated by Targeted Deletion of the Mycobacterium bovis Virulence Factor VapC40. International Journal of Molecular Sciences, 27(9), 4067. https://doi.org/10.3390/ijms27094067
Vancouver
Ge X, Wang H, Liu D, Dong Y, Li L, Shen P, et al. A Highly Protective Live-Attenuated Vaccine Generated by Targeted Deletion of the Mycobacterium bovis Virulence Factor VapC40. International Journal of Molecular Sciences. 2026;27(9):4067. doi:10.3390/ijms27094067
BibTeX
@article{Ge2026,
author = {Ge, Xin and Wang, Haoran and Liu, Dingpu and Dong, Yuhui and Li, Lin and Shen, Puxiu and Li, Yue and Zhang, Jiaming and Zhou, Xiangmei and Yue, Ruichao},
title = {A Highly Protective Live-Attenuated Vaccine Generated by Targeted Deletion of the Mycobacterium bovis Virulence Factor VapC40},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {4067},
doi = {10.3390/ijms27094067}
}
EUVIMED